#MediaUpdate Very pleased to see Alvotech's ustekinumab biosimilar receive approval in Europe. This is an important milestone for the business and we're excited to be improving healthcare access and widening competition in this important market. investors.alvotech.com/news-releases/…

We greatly value each individual’s unique culture, insight and background to give us a comprehensive view of the world we look to make an impact on. Find out how Alvotech has attracted some of the industry’s most talented individuals here: youtube.com/watch?v=hEU-F2…

This is an interesting development in the US that could help to increase competition in our industry and ultimately improve patient access. Interested to see this progress! New congressional bill would thwart patent thickets (statnews.com)

Three goals and three points! ❤️👏 #MUFC || #MUNWHU

📸 Good goal, great celebration. The first of another Old Trafford double for @AGarnacho7 ✌️ #MUFC || #MUNWHU

As we near #InternationalDayOfWomenAndGirlsInScience, we celebrate Alvotech's Equal Pay Certification under the Icelandic Equal Pay Standard. Learn more about Alvotech's initiatives here: alvotech.com/corporate-sust…

Recently I spoke to @Rouleur about my passion for cycling and the impact a major bike crash had on my life in 2013. It was a pleasure to share how cycling has shaped my daily life and improved the way I work. #Cycling

February 29th is #RareDiseaseDay. On this day, we recognise 300 million people worldwide living with a rare disease, their families and carers.

Although not the result Manchester United were looking for, an achievement to get the first goal within 8 mins against a team of that quality in the derby. Onwards and upwards!

Looking around @Alvotech, I'm inspired by the diversity of our team – with 60+ different nationalities, it's clear our strength truly lies in our differences. We’re committed to equality in healthcare, and it starts within our organisation. Read more: alvotech.com/corporate-sust…

During #NeurodiversityCelebrationWeek, it's essential to consider the significance of neurodiversity in our communities. By understanding and valuing #neurodiversity, we strengthen our society and promote an inclusive environment that appreciates the talents of all. #Inclusion

Thanks to all who honored us by attending the Grand Opening for Alvotech's facility extension. Only 3 years passed since we broke ground and our staff has moved in. We are looking forward to telling you about R&D milestones and multiple global launches of our biosimilars.

Wishing all my colleagues, followers, and friends a very Happy Easter - from my family to yours. May your Easter be filled with happiness, gratitude, peace, and the warmth of the spring sun. #Easter2024

A very successful opening event for Alvotech's new facility in Reykjavik last week! Extremely proud of our team's hard work.

#InvestorUpdate @Alvotech has received its second U.S. FDA approval for a proposed #biosimilar. A significant stride in #HealthcareInnovation and enhancing #AccessibleHealthcare. Find out more here: investors.alvotech.com/news-releases/…

#ClinicalMilestone Thrilled to share positive top-line results from a @AlvotechPR’s confirmatory patient study for the third time this year. Thanks to our teams, with special kudos to the clinical and medical affairs team for stellar results. Read more investors.alvotech.com/news-releases/…

I had the incredible opportunity to attend the #Wimbledon final. The determination, focus, and resilience of the players were truly inspiring. Let's bring that same spirit to our professional lives, pushing through challenges and striving for excellence every day!

Biosimilars are key to expanding access to top treatments globally. They offer cost-effective options and drive innovation by introducing competition in healthcare. We're committed to delivering affordable, high-quality care to patients everywhere. #Biosimilars #Innovation

Today on #InternationalEqualPayDay, I'm proud to highlight Alvotech's Equal Pay Policy and Certification. By championing #genderequality, we create a more dynamic workplace and inclusive economy.

#MediaUpdate Delighted to see the European Medicines Agency accept our marketing authorization application. This is an important step towards making our proposed biosimilar available to patients and caregivers. investors.alvotech.com/news-releases/…